All Stories

  1. ChatGPT and Corporations of Mega-journals Jeopardize the Norms That Underpin Academic Publishing
  2. SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19
  3. Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis
  4. Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis
  5. ‘The end’ – Or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 Subvariants
  6. Passive Contribution of ChatGPT to Scientific Papers
  7. ChatGPT and Publication Ethics
  8. The prevalence of antibiotic-resistant Acinetobacter baumannii infections among the Iranian ICU patients: A systematic review and meta-analysis
  9. Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
  10. Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer
  11. Poliomyelitis outbreaks caused by circulation of the vaccine-derived poliovirus
  12. WHO declared monkeypox a public-health emergency of international concern: A case for prevention rationale
  13. COVID-19 and science diplomacy
  14. Immediate countermeasures against the monkeypox outbreak
  15. Implications of the SARS-CoV-2 subvariants BA.4 and BA.5
  16. The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries
  17. Hybrid SARS-CoV-2 variants
  18. The Ukrainian refugee crisis and the COVID-19 pandemic in Europe
  19. Omicron: A highly transmissible SARS-CoV-2 variant
  20. Detection of the XE subvariant of SARS-CoV-2: A perspective
  21. Is Omicron the last SARS-CoV-2 Variant of Concern?
  22. Learning from Retracted Papers Authored by the Highly Cited Iran-affiliated Researchers: Revisiting Research Policies and a Key Message to Clarivate Analytics
  23. Highly contagious but less severe COVID-19 caused by new SARS-CoV-2 sublineages may abate the pandemic
  24. WHO prequalified tocilizumab and vaccine boosters against COVID-19
  25. The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic
  26. A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
  27. The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic
  28. SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
  29. The third booster vaccination dose against COVID-19: indications for circulating SARS-CoV-2 variants
  30. Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
  31. Isolation of dupA-positive and clarithromycin-resistant Helicobacter pylori from Iranian patients with duodenal ulcer
  32. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
  33. Identification of Helicobacter pylori in tumor biopsies obtained from patients with colorectal cancer: Indication for a prophylactic vaccine?
  34. Identification of Helicobacter pylori in tumor biopsies obtained from patients with colorectal cancer: Indication for a prophylactic vaccine?
  35. Alzheimer Disease: Controversies in Basic Science Research, Different Theories, and Reasons for Failed Trials
  36. Plagiarism, Fake Peer-Review, and Duplication: Predominant Reasons Underlying Retractions of Iran-Affiliated Scientific Papers
  37. Criticality of physical/social distancing, handwashing, respiratory hygiene and face‐masking during the COVID‐19 pandemic and beyond
  38. Host Porphobilinogen Deaminase Deficiency Confers Malaria Resistance in Plasmodium chabaudi but Not in Plasmodium berghei or Plasmodium falciparum During Intraerythrocytic Growth
  39. Challenges of managing the asymptomatic carriers of SARS-CoV-2
  40. The Uncertainties Underlying Herd Immunity against COVID-19
  41. Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases
  42. Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2
  43. Tackling the COVID-19 Pandemic
  44. Ethical and Sensible Dissemination of Information During the COVID-19 Pandemic
  45. Criticality of physical/social distancing, handwashing, respiratory hygiene, and face-masking during the COVID-19 pandemic and beyond
  46. Unguided research and noncompliance may have intensified the COVID-19 pandemic
  47. <p>Colonization by <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> of Antral Biopsy Specimens from Gastritis Patients Uninfected with <em>Helicobacter Pylori</em></p>
  48. Transparency and information sharing could help abate the COVID-19 pandemic
  49. Practical Strategies Against the Novel Coronavirus and COVID-19—the Imminent Global Threat
  50. FadA-positive Fusobacterium nucleatum is prevalent in the biopsy specimens of Iranian patients with colorectal cancer
  51. Tracking the Virulent Helicobacter pylori Strains Instead of Its Pan-Screening to Prevent Gastric Cancer
  52. Helicobacter heilmannii Colonization Is Associated With High Risk for Gastritis
  53. Present Challenges Besetting the Iranian Academia
  54. Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
  55. Host porphobilinogen deaminase deficiency confers malaria resistance in Plasmodium chabaudi but not in Plasmodium falciparum or Plasmodium berghei during intraerythrocytic growth
  56. Characterization of the ATP4 ion pump in Toxoplasma gondii
  57. Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells
  58. Large expert-curated database for benchmarking document
  59. Aptamers Selected for Recognizing Amyloid β-Protein—A Case for Cautious Optimism
  60. Aptamers Selected for Recognizing Amyloid β-protein—A Case for Cautious Optimism
  61. Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity
  62. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells
  63. Modulators of Amyloid β-Protein (Aβ) Self-Assembly
  64. Methods for Studying and Structure–Function Relationships of Non-Fibrillar Protein Assemblies in Alzheimer's Disease and Related Disorders
  65. Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01
  66. Zn2+-Aβ40 Complexes Form Metastable Quasi-spherical Oligomers That Are Cytotoxic to Cultured Hippocampal Neurons
  67. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases
  68. Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins
  69. Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
  70. RNA Aptamers Generated against Oligomeric Aβ40 Recognize Common Amyloid Aptatopes with Low Specificity but High Sensitivity
  71. Amyloids and Protein Aggregation-Analytical Methods
  72. Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease
  73. Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture
  74. Photo-Induced Cross-Linking of Unmodified Proteins (PICUP) Applied to Amyloidogenic Peptides
  75. Structure – Function Relationships of Pre-Fibrillar Protein Assemblies in Alzheimers Disease and Related Disorders
  76. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease
  77. Antigen-Epitope Retrieval To Facilitate Proteomic Analysis of Formalin-Fixed Archival Brain Tissue
  78. S100A8 and S100A9 in Human Arterial Wall
  79. FGF-2, IL-1β and TGF-β regulate fibroblast expression of S100A8
  80. Regulation of S100A8 by Glucocorticoids
  81. Probing the S100 protein family through genomic and functional analysis
  82. Pick bodies in a family with presenilin-1 Alzheimer's disease